نتایج جستجو برای: upper arm length

تعداد نتایج: 561476  

2015
Jennifer Huberty Diane K. Ehlers Jonathan Kurka Barbara Ainsworth Matthew Buman

BACKGROUND The purpose of this study is to determine the feasibility of three widely used wearable sensors in research settings for 24 h monitoring of sleep, sedentary, and active behaviors in middle-aged women. METHODS Participants were 21 inactive, overweight (M Body Mass Index (BMI) = 29.27 ± 7.43) women, 30 to 64 years (M = 45.31 ± 9.67). Women were instructed to wear each sensor on the n...

Journal: :Work 2012
C Castro E De la Vega G Báez F Carrasco

The number of occupational diseases in Mexico is alarming and clearly it is important to do studies with the purpose of improving the design of workstations. The objective of this research is to determine the maximum force levels in different positions of shoulder and elbow. An experiment was conducted with 16 subjects between 18 and 28 years old: 8 male and 8 female. We considered 16 different...

Journal: :Journal of motor behavior 2008
Clara Moisello Marco Bove Reto Huber Giovanni Abbruzzese Fortunato Battaglia Giulio Tononi M Felice Ghilardi

C. Ghez, J. Gordon, and M. R Ghilardi (1995; J. Gordon, M. R Ghilardi, & C. Ghez, 1995; R. L. Sainburg, M. R Ghilardi, H. Poizner, & C. Ghez, 1995) have found that proprio-ceptive deafferentation impairs feedforward and feedback mechanisms that control reaching movements. In the present study, the authors found immobilization-induced changes in limb kinematics, including joint motion, in 32 hea...

Journal: :International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2000
A V Sauerbronn A M Fonseca V R Bagnoli P H Saldiva J A Pinotti

OBJECTIVE The aim of this study was to determine the effects of hormonal replacement therapy on the skin of postmenopausal women. METHOD Forty-one postmenopausal women were randomly allocated to receive either hormonal replacement (valerate estradiol--2 mg/day for 21 days and cyproterone acetate--1 mg/day for 10 days) or placebo, both in a cyclic scheme for 6 months. Neither patients nor inve...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید